Butyryl-CoA
Butyryl-CoA[edit | edit source]
Butyryl-CoA is an important molecule involved in various metabolic pathways within living organisms. It is a coenzyme A (CoA) ester of butyric acid, a four-carbon saturated fatty acid. Butyryl-CoA plays a crucial role in the metabolism of fatty acids, amino acids, and carbohydrates.
Structure[edit | edit source]
The structure of Butyryl-CoA consists of a butyric acid molecule attached to a coenzyme A molecule through a thioester bond. The coenzyme A portion of the molecule contains a pantothenic acid moiety, a nucleotide, and a terminal sulfhydryl group. This sulfhydryl group forms a high-energy thioester bond with the carboxyl group of butyric acid, resulting in the formation of Butyryl-CoA.
Function[edit | edit source]
Butyryl-CoA is involved in several metabolic pathways, including fatty acid metabolism, amino acid metabolism, and carbohydrate metabolism.
In fatty acid metabolism, Butyryl-CoA serves as an intermediate in the breakdown of fatty acids. It is produced during the beta-oxidation of fatty acids, where long-chain fatty acids are sequentially shortened by removing two-carbon units. Butyryl-CoA is further metabolized to acetyl-CoA, which enters the citric acid cycle for energy production.
In amino acid metabolism, Butyryl-CoA participates in the degradation of certain amino acids, such as valine and isoleucine. These amino acids are converted into their corresponding CoA derivatives, including Butyryl-CoA, before being further metabolized.
Butyryl-CoA also plays a role in carbohydrate metabolism. During the process of gluconeogenesis, Butyryl-CoA can be converted into succinyl-CoA, which is an intermediate in the citric acid cycle. Succinyl-CoA can then be used for the synthesis of glucose.
Clinical Significance[edit | edit source]
Abnormalities in Butyryl-CoA metabolism can lead to various metabolic disorders. For example, deficiencies in enzymes involved in the breakdown of Butyryl-CoA can result in disorders such as butyryl-CoA dehydrogenase deficiency and medium-chain acyl-CoA dehydrogenase deficiency. These conditions can cause symptoms such as hypoglycemia, lethargy, and muscle weakness.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD